CORCEPT THERAPEUTICS INC Unrecognized Tax Benefits, Period Increase (Decrease)
CORCEPT THERAPEUTICS INC (CORT) reported Unrecognized Tax Benefits, Period Increase (Decrease) of -$700.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease · last filed 2026-07-29
- CORCEPT THERAPEUTICS INC unrecognized tax benefits, period increase (decrease) for the quarter ending 2026-06-30 was -$700.00K, a 138.89% decline year-over-year.
- CORCEPT THERAPEUTICS INC unrecognized tax benefits, period increase (decrease) for the quarter ending 2026-03-31 was $700.00K, a 600.00% increase year-over-year.
- CORCEPT THERAPEUTICS INC unrecognized tax benefits, period increase (decrease) for the quarter ending 2025-09-30 was $900.00K, a 30.77% decline year-over-year.
- CORCEPT THERAPEUTICS INC unrecognized tax benefits, period increase (decrease) for the quarter ending 2025-06-30 was $1.80M, a 28.57% increase year-over-year.
| Period end | Unrecognized Tax Benefits, Period Increase (Decrease) 3 month | Unrecognized Tax Benefits, Period Increase (Decrease) 6 month | Unrecognized Tax Benefits, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2026-06-30 | -$700.00K 10-Q · filed 2026-07-29 | $100.00K 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $700.00K 10-Q · filed 2026-04-30 | ||
| 2025-09-30 | $900.00K 10-Q · filed 2025-11-04 | $2.70M derived: sum of 2 quarters · filed 2025-11-04 | $2.70M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $1.80M 10-Q · filed 2025-07-31 | $1.90M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-05 | ||
| 2024-09-30 | $1.30M 10-Q · filed 2024-10-30 | $2.70M derived: sum of 2 quarters · filed 2024-10-30 | $3.40M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $1.40M 10-Q · filed 2024-07-29 | $2.00M 10-Q · filed 2024-07-29 | |
| 2024-03-31 | $700.00K 10-Q · filed 2024-05-01 | ||
| 2023-09-30 | $700.00K 10-Q · filed 2023-11-01 | $1.40M derived: sum of 2 quarters · filed 2023-11-01 | $1.80M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $700.00K 10-Q · filed 2023-08-02 | $1.10M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $400.00K 10-Q · filed 2023-05-03 | ||
| 2022-09-30 | $600.00K 10-Q · filed 2022-11-03 | $1.20M derived: sum of 2 quarters · filed 2022-11-03 | $1.60M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $600.00K 10-Q · filed 2022-08-04 | $1.00M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $400.00K 10-Q · filed 2022-05-05 | ||
| 2021-09-30 | $600.00K 10-Q · filed 2021-11-03 | $1.20M derived: sum of 2 quarters · filed 2021-11-03 | $1.40M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $600.00K 10-Q · filed 2021-07-29 | $800.00K 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $200.00K 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |